Literature DB >> 11070012

Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.

H M Liu1, D P Zheng, L B Zhang, M S Oberste, M A Pallansch, O M Kew.   

Abstract

Type 1 wild-vaccine recombinant polioviruses were isolated from poliomyelitis patients in China from 1991 to 1993. We compared the sequences of 34 recombinant isolates over the 1,353-nucleotide (nt) genomic interval (nt 2480 to 3832) encoding the major capsid protein, VP1, and the protease, 2A. All recombinants had a 367-nt block of sequence (nt 3271 to 3637) derived from the Sabin 1 oral poliovirus vaccine strain spanning the 3'-terminal sequences of VP1 (115 nt) and the 5' half of 2A (252 nt). The remaining VP1 sequences were closely (up to 99.5%) related to those of a major genotype of wild type 1 poliovirus endemic to China up to 1994. In contrast, the non-vaccine-derived sequences at the 3' half of 2A were more distantly related (<90% nucleotide sequence match) to those of other contemporary wild polioviruses from China. The vaccine-derived sequences of the earliest (April 1991) isolates completely matched those of Sabin 1. Later isolates diverged from the early isolates primarily by accumulation of synonymous base substitutions (at a rate of approximately 3.7 x 10(-2) substitutions per synonymous site per year) over the entire VP1-2A interval. Distinct evolutionary lineages were found in different Chinese provinces. From the combined epidemiologic and evolutionary analyses, we propose that the recombinant virus arose during mixed infection of a single individual in northern China in early 1991 and that its progeny spread by multiple independent chains of transmission into some of the most populous areas of China within a year of the initiating infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070012      PMCID: PMC113202          DOI: 10.1128/jvi.74.23.11153-11161.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Genetic recombination with Newcastle disease virus, polioviruses, and influenza.

Authors:  G K HIRST
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Identification and characterization of foot-and-mouth disease virus O1 Burgwedel/1987 as an intertypic recombinant.

Authors:  O Krebs; O Marquardt
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

Review 3.  Antigenic structure of picornaviruses.

Authors:  P D Minor
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

5.  Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.

Authors:  M Benyesh-Melnick; J L Melnick; W E Rawls; I Wimberly; J B Oro; E Ben-Porath; V Rennick
Journal:  Am J Epidemiol       Date:  1967-07       Impact factor: 4.897

Review 6.  A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes.

Authors:  W H Li; C I Wu; C C Luo
Journal:  Mol Biol Evol       Date:  1985-03       Impact factor: 16.240

7.  Intertypic genomic rearrangements of poliovirus strains in vaccinees.

Authors:  N Cammack; A Phillips; G Dunn; V Patel; P D Minor
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

8.  Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus.

Authors:  D J Filman; R Syed; M Chow; A J Macadam; P D Minor; J M Hogle
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

9.  Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences.

Authors:  A M King
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

10.  The mechanism of RNA recombination in poliovirus.

Authors:  K Kirkegaard; D Baltimore
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

View more
  45 in total

1.  Imbroglios of viral taxonomy: genetic exchange and failings of phenetic approaches.

Authors:  Jeffrey G Lawrence; Graham F Hatfull; Roger W Hendrix
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

2.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses.

Authors:  M Steven Oberste; Silvia Peñaranda; Mark A Pallansch
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.

Authors:  Ekaterina A Korotkova; Renee Park; Elena A Cherkasova; Galina Y Lipskaya; Konstantin M Chumakov; Esfir V Feldman; Olen M Kew; Vadim I Agol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Evolution of 2B and 2C genomic parts of species B Coxsackie viruses. Phylogenetic study and comparison with other regions.

Authors:  Eugenia Bolanaki; Christine Kottaridi; Panayotis Markoulatos; Lukas Margaritis; Theodoros Katsorchis
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

8.  Diagnostic Assay Development for Poliovirus Eradication.

Authors:  Nancy Gerloff; Hong Sun; Mark Mandelbaum; Chelsea Maher; W Allan Nix; Sohail Zaidi; Shahzad Shaukat; Lerato Seakamela; Uma P Nalavade; Deepa K Sharma; M Steven Oberste; Everardo Vega
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

9.  Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.

Authors:  Hong-Mei Liu; Du-Ping Zheng; Li-Bi Zhang; M Steven Oberste; Olen M Kew; Mark A Pallansch
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

Authors:  Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van der Avoort
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.